Publication | Open Access
DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
43
Citations
36
References
2020
Year
DCLK1 characterizes a specific CSC subpopulation of iCCA<sup>CD133+</sup> and pCCA<sup>LGR5+</sup> , and its inhibition exerts anti-neoplastic effects in primary CCA cell cultures. Human DCLK1 serum might represent a serum biomarker for the early CCA diagnosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1